Direct adsorption scintillation assay for measuring enzyme activity and assaying biochemical processes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6977141
APP PUB NO 20020015678A1
SERIAL NO

09248158

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods and materials for scintillation assays are disclosed. The scintillation assays rely on differences in general molecular property-based binding interactions, such as charge or hydrophobicity, to localize a radioactive substance near a scintillating material, stimulating scintillation. They are thus described as a direct adsorption scintillation assay (DASA) to distinguish them from the scintillation proximity assay (SPA). The assays are more convenient and inexpensive to implement than SPAs, which rely on specific binding of ligand-receptor pairs, antibody-antigen pairs, or other binding partners which rely on the precise and specific structural complementarity of the partners. The assays can be employed for studying enzymatic reactions, such as those involved in the synthesis of Mur-pentapeptide. The assays are readily adaptable to high throughput screening for use in conjunction with combinatorial libraries of compounds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VICURON PHARMACEUTICALS INC455 SOUTH GULPH ROAD KING OF PRUSSIA PA 19406

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Zhong-Xiao Belmont, CA 1 2
Yuan, Zhengyu Fremont, CA 35 260

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation